Expanding Plasma-Derived Therapies in the US Plasma Fractionation Market
The escalating demand for plasma-derived therapies is reshaping the landscape of the US Plasma Fractionation Market. With a projected market size soaring to $17 billion by 2035, the growth trajectory is underscored by an impressive compound annual growth rate (CAGR) of 6.5%. This upward trend reflects not just a surge in production capabilities but a rising awareness of the critical role that...
0 Comments 0 Shares 39 Views 0 Reviews